?
Profile and Organization

Names, Facts, Figures about Bayer

Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time.

Bayer group

The Bayer Cross is one of the world′s best-known trademarks

A growing and aging world population requires an adequate supply of food and improved medical care. With our innovative products, we are contributing to finding solutions to some of the major challenges of our time. With life expectancy continuing to rise, we improve quality of life for a growing population by focusing our research and development activities on preventing, alleviating and treating diseases. We are also making an important contribution to providing a reliable supply of high-quality food, feed and plant-based raw materials.

Our goal is to create value for our customers, stockholders and employees, while also strengthening the company’s earning power. We are committed to operating sustainably and addressing our social and ethical responsibilities. Employees with a passion for innovation enjoy excellent development opportunities at Bayer. All this goes to make up our purpose:

Exclusive Focus on the Life Science Businesses

The Bayer Group is managed as a life science company with three divisions – Pharmaceuticals, Consumer Health and Crop Science – and the Animal Health business unit, which are also our reporting segments. The corporate functions, Business Services and the service company Currenta support the operational business. In 2018, the Bayer Group comprised 420 consolidated companies in 90 countries throughout the world.

Structure of the Bayer Group

Board of Management Pharmaceuticals Consumer Health Crop Science Animal Health Corporate Functions & Business Services Currenta (60%)
Board of Management Pharmaceuticals Consumer Health Crop Science Animal Health Corporate Functions & Business Services Currenta (60%)

Business Operations Are the Responsibility of the Divisions

Bayer Divisions: Pharmaceuticals (prescription products)

The Pharmaceuticals division focuses on prescription products, especially for cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology. The division also comprises the radiology business, which markets diagnostic imaging equipment together with the necessary contrast agents.

Bayer Divisions: Consumer Health (non-prescription products)

The Consumer Health division markets mainly nonprescription (OTC = over-the-counter) products in the dermatology, nutritional supplement, analgesic, digestive health, cold, allergy, sinus and flu categories.

Bayer Divisions: Crop Science (Crop Protection)

The Crop Science division is a world-leading agriculture enterprise with businesses in seeds, crop protection and nonagricultural pest control. The Crop Protection / Seeds operating unit markets a broad portfolio of high-value seeds and innovative pest management solutions, while at the same time providing extensive customer service for sustainable agriculture. The Environmental Science operating unit provides products and services for professional nonagricultural applications, such as vector and pest control and forestry.


Bayer Divisions: Animal Health

The Animal Health business unit ranks among the leading international innovators in its field. It develops and markets products and solutions for the prevention and treatment of diseases in companion and farm animals.


Central Service Functions

Bayer Service Functions: Bayer Business Services

The corporate functions and Business Services operate as Group-wide competence centers in which business support services are bundled.

Bayer Servicefunctions: Currenta

Currenta is the service company responsible for managing and operating the Chempark sites in Leverkusen, Dormagen and Krefeld-Uerdingen.


Corporate Governance

Dual governance system with the following governance bodies:

Board of Management:

seven members, Chairman: Werner Baumann

Supervisory Board:

20 members, Chairman: Werner Wenning

Products

Bayer Products - medicine and agriculture

With our products, we are contributing to finding solutions to some of the major challenges of our time. The growing and increasingly aging world population requires improved medical care and an adequate supply of food. Bayer is improving peo-ple’s quality of life by preventing, alleviating and curing diseases. And we are helping to provide a reliable supply of high-quality food, feed and plant-based raw materials.

Bayer’s extensive product portfolio contains numerous globally renowned brands.

Best-selling Bayer products are:

  • in the Pharmaceuticals field: Xarelto?, Eylea?, Adempas?, Xofigo?, Stivarga?, Mirena?-Produktfamilie, Kogenate? / Kovaltry? / Jivi?, Nexavar?, YAZ? / Yasmin? / Yasminelle?, Glucobay?, Adalat?, Aspirin? Cardio, Betaferon? / Betaseron?, Gadavist? / Gadovist? and Stellant?
  • in the Consumer Health field: Claritin?, Aspirin?, Bepanthen? / Bepanthol? Aleve?, Canesten?, Alka-Seltzer?-Produktfamilie, Elevit?, One A Day? and MiraLAX?
  • the key brands in the agriculture field are: Confidor? / Gaucho? /Nativo?-Produktfamilie und die Prosaro?-Produktfamilie
  • in the Animal Health field: the Advantage?-Produktfamilie, Seresto?, the Drontal?-Produktfamilie and Baytril?

Locations

The Bayer Group comprises 420 consolidated companies** in 90 countries throughout the world. Global headquarters are in Leverkusen, Germany.

** fully consolidated subsidiaries (as of December. 31, 2018)

Our Employees

On December 31, 2018, Bayer employed 116,998 (2017: 99,820) people worldwide. In Germany we had 32,140 (2017: 31,620) employees, which was 27.5% of the total Bayer Group workforce (2017: 31.7%).

Employees by Region and Gender in 2018

Bayer employees worldwide

Bayer Stock

Bayer Group Key Data

Bayer Group 20172018 Change
  € million€ million %
Sales 35.01539.586 13,1
EBIT1 5.9033.914 -33,7
EBIT before special items2 7.1306.480 -9,1
EBITDA3 8.56310.266 19,9
EBITDA before special items2 9.2889.547 2,8
EBITDA margin before special items (in %)4 26,524,1 -9,0
Income before income taxes 4.5772.318 -49,4
Net income 7.3361.695 -76,9
Earnings per share (€)5 8,291,80 -78,3
Core earnings per share (€)6 6,645,94 -10,5
Net financial debt 3.59535.679 892,5
Capital expenditures as per segment table 2.4182.564 6,0
Research and development expenses 4.5045.246 16,5
Dividend per Bayer AG share (€) 2,802,80 0

figures restated
1-6 for definition see footnotes to alternative performance measures Bayer Group (as of Dec. 31, 2018)